English മലയാളം

Blog

bharat-biotech-covaxin-packshot

Web Desk

The Indian Council of Medical Research (ICMR) has partnered with Bharat Biotech International Limited (BBIL) to fast track clinical trials of the indigenous COVID-19 vaccine. ICMR’s National Institute of Virology (NIV) in Pune has provided the virus strain to BBIL to develop the vaccine.

Also read:  New Zealand health minister quits

The clinical trials will be held in 12 institutes across the country. In a letter to these institutes, the ICMR stated that it aims to launch the vaccine for public health use by August 15, after completion of all clinical trials.

Also read:  At least five lakh sharks to be slaughtered to make COVID-19 vaccines

Meanwhile, India’s second COVID-19 vaccine produced pharma giant Zydus Cadila got approval from the Drug Controller General of India (DCGI) to conduct phase I and phase II human clinical trials.